Brief Cognitive Behavioral Conjoint Therapy (bCBCT) + MIDOMAFETAMINE for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Aug 2023: Trial registered, NCT05979844
  2. 6 Oct 2023: Trial started, NCT05979844

The trials

NCT05979844: MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD

State
Completed
Phase
Phase 3
People
16 taking part
Started
6 Oct 2023
Primary completion
14 Nov 2025
Arms
Non-medicine sessions of bCBCT + Medicine Sessions with 3,4-methylenedioxymethamphetamine (MDMA)
Results
None posted
  1. 7 Aug 2023: Trial registered
  2. 6 Oct 2023: Trial started
  3. 14 Nov 2025: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.